Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies

por Amoroso, V., Gallo, F., Alberti, A., Paloschi, D., Ferrari Bravo, W., Esposito, A., Cosentini, D., Grisanti, S., Pedersini, R., Petrelli, F., Berruti, A.
Publicado 2023

Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma

por Laganà, M., Grisanti, S., Ambrosini, R., Cosentini, D., Abate, A., Zamparini, M., Ferrari, V.D., Gianoncelli, A., Turla, A., Canu, L., Terzolo, M., Tiberio, G.A.M., Sigala, S., Berruti, A.
Publicado 2022

1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic

por Gurizzan, C., Pedersini, R., Fornaro, C., Sardini, C., Zamparini, M., Monteverdi, S., Tovazzi, V., Cosentini, D., Dalla Volta, A., Baggi, A., Turla, A., Di Mauro, P., Lorini, L., Laganà, M., Bianchi, S., Intagliata, S., Consoli, F., Conti, E., Bossi, P., Berruti, A.
Publicado 2020

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study

por Elhassan, Y S, Altieri, B, Berhane, S, Cosentini, D, Calabrese, A, Haissaguerre, M, Kastelan, D, Fragoso, M C B V, Bertherat, J, Al Ghuzlan, A, Haak, H, Boudina, M, Canu, L, Loli, P, Sherlock, M, Kimpel, O, Laganà, M, Sitch, A J, Kroiss, M, Arlt, W, Terzolo, M, Berruti, A, Deeks, J J, Libé, R, Fassnacht, M, Ronchi, C L
Publicado 2021